1. Home
  2. BIAF vs LDWY Comparison

BIAF vs LDWY Comparison

Compare BIAF & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • LDWY
  • Stock Information
  • Founded
  • BIAF 2014
  • LDWY 1990
  • Country
  • BIAF United States
  • LDWY United States
  • Employees
  • BIAF N/A
  • LDWY N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LDWY Advertising
  • Sector
  • BIAF Health Care
  • LDWY Consumer Discretionary
  • Exchange
  • BIAF Nasdaq
  • LDWY Nasdaq
  • Market Cap
  • BIAF 7.6M
  • LDWY 8.9M
  • IPO Year
  • BIAF 2022
  • LDWY 1991
  • Fundamental
  • Price
  • BIAF $3.24
  • LDWY $4.90
  • Analyst Decision
  • BIAF Hold
  • LDWY
  • Analyst Count
  • BIAF 1
  • LDWY 0
  • Target Price
  • BIAF N/A
  • LDWY N/A
  • AVG Volume (30 Days)
  • BIAF 7.6M
  • LDWY 3.0K
  • Earning Date
  • BIAF 11-13-2025
  • LDWY 11-18-2025
  • Dividend Yield
  • BIAF N/A
  • LDWY N/A
  • EPS Growth
  • BIAF N/A
  • LDWY N/A
  • EPS
  • BIAF N/A
  • LDWY 1.66
  • Revenue
  • BIAF $7,681,059.00
  • LDWY $71,244,000.00
  • Revenue This Year
  • BIAF N/A
  • LDWY N/A
  • Revenue Next Year
  • BIAF $20.04
  • LDWY N/A
  • P/E Ratio
  • BIAF N/A
  • LDWY $3.02
  • Revenue Growth
  • BIAF 4.99
  • LDWY 187.12
  • 52 Week Low
  • BIAF $2.34
  • LDWY $3.02
  • 52 Week High
  • BIAF $67.12
  • LDWY $6.19
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 53.34
  • LDWY 44.44
  • Support Level
  • BIAF $2.36
  • LDWY $4.57
  • Resistance Level
  • BIAF $7.29
  • LDWY $5.45
  • Average True Range (ATR)
  • BIAF 0.63
  • LDWY 0.19
  • MACD
  • BIAF -0.30
  • LDWY -0.03
  • Stochastic Oscillator
  • BIAF 23.73
  • LDWY 32.04

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

Share on Social Networks: